Heart-type fatty acid binding proteins are upregulated during terminal differentiation of mouse cardiomyocytes, as revealed by proteomic analysis

Cell and Tissue Research

Volumn 316, Issue 3, 2004, Pages 339-347

  Tang, M K ^a   Kindler, P M ^a   Cai, D Q ^b   Chow, P H ^a   Li, M ^c   Lee, K K H ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b JINAN UNIVERSITY   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cell proliferation; H FABP; Heart; MALDI TOF; Mouse (ICR); Two dimensional gel electrophoresis

Indexed keywords

CYCLINE; FATTY ACID BINDING PROTEIN; MONOCLONAL ANTIBODY;

ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; GEL ELECTROPHORESIS; HEART; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; FATTY ACID-BINDING PROTEINS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED ICR; MYOCARDIUM; MYOCYTES, CARDIAC; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN ISOFORMS; PROTEOMICS; UP-REGULATION;

EID: 3042693944     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-004-0881-y     Document Type: Article

References (30)

1. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P (2001) Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344:1750-1757
2. Binas B, Danneberg H, McWhir J, Mullins L, Clark AJ (1999) Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. FASEB J 13:805-812
3. Bohmer FD, Kraft R, Otto A, Wernstedt C, Hellman U, Kurtz A, Muller T, Rohde K, Etzold G, Lehmann W (1987) Identification of a polypeptide growth inhibitor from bovine mammary gland. Sequence homology to fatty acid- and retinoid-binding proteins. J Biol Chem 262:15137-15143
4. Borchers T, Unterberg C, Rudel H, Robenek H, Spener F (1989) Subcellular distribution of cardiac fatty acid-binding protein in bovine heart muscle and quantitation with an enzyme-linked immunosorbent assay. Biochim Biophys Acta 1002:54-61
5. Brooks G, Poolman RA, McGill CJ, Li JM (1997) Expression and activities of cyclins and cyclin-dependent kinases in developing rat ventricular myocytes. J Mol Cell Cardiol 29:2261-2271
6. Buhlmann C, Borchers T, Pollak M, Spener F (1999) Fatty acid metabolism in human breast cancer cells (MCF7) transfected with heart-type fatty acid binding protein. Mol Cell Biochem 199:41-48
7. Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC, Nevins JR (1992) Adeno virus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. PNAS (USA) 89:4549-4553
8. Claycomb WC (1992) Control of cardiac muscle division. Trends Cardiovasc Med 2:231-236
9. Das R, Hammamieh R, Neill R, Melhem M, Jett M (2001) Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues. Clin Cancer Res 7:1706-1715
10. Duplus E, Glorian M, Forest C (2000) Fatty acid regulation of gene transcription [Review]. J Biol Chem 275:30749-30752
11. Flink IL (2002) Cell cycle reentry of ventricular and atrial cardiomyocytes and cells within the epicardium following amputation of the ventricular apex in the axolotl, Amblystoma mexicanum: confocal microscopic immunofluorescent image analysis of bromodeoxyuridine-labeled nuclei. Anat Embryol 205:235-244
12. Flink IL, Oana S, Maitra N, Bahl JJ, Morkin E (1998) Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes. J Mol Cell Cardiol 30:563-578
13. Huynh HT, Larsson C, Narod S, Pollak M (1995) Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor. Cancer Res 55:2225-2231
14. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, Anversa P (1998) Myocyte proliferation in end-stage cardiac failure in humans. PNAS (USA) 95:8801-8805
15. Lam EW, Watson RJ (1993) An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J 12:2705-2713
16. Leferovich JM, Bedelbaeva K, Samulewicz S, Zhang XM, Zwas D, Lankford EB, Heber-Katz E (2001) Heart regeneration in adult MRL mice. PNAS (USA) 98:9830-9835
17. Li F, Wang X, Capasso JM, Gerdes AM (1996) Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 28:1737-1746
18. Marino TA, Haldar S, Williamson EC, Beaverson K, Walter RA, Marino DR, Beatty C, Lipson KE (1991) Proliferating cell nuclear antigen in developing and adult rat cardiac muscle cells. Circ Res 69:1353-1360
19. McGill CJ, Brooks G (1995) Cell cycle control mechanisms and their role in cardiac growth [review]. Cardiovasc Res 30:557-569
20. Niwelinski J, Rumyantsev PP, Jonek JJ, Zamorska L, Konecki J, Kaminski M (1974) Histoenzymological observations of the response to injury and regeneration of the frog myocardium. Folia Histochem Cytochem 12:93-109
21. Quaini F, Cigola E, Lagrasta C, Saccani G, Quaini E, Rossi C, Olivetti G, Anversa P (1994) End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ Res 75:1050-1063
22. Rump R, Buhlmann C, Borchers T, Spener F (1996) Differentiation-dependent expression of heart type fatty acid-binding protein in C2C12 muscle cells. Eur J Cell Biol 69:135-142
23. Sauro VS, Strickland KP (1987) Changes in oleic acid oxidation and incorporation into lipids of differentiating L6 myoblasts cultured in normal or fatty acid-supplemented growth medium. Biochem J 244:743-748
24. Schaap FG, Binas B, Danneberg H, van der Vusse GJ, Glatz JF (1999) Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene. Circ Res 85:329-337
25. Specht B, Bartetzko N, Hohoff C, Kuhl H, Franke R, Borchers T, Spener F (1996) Mammary derived growth inhibitor is not a distinct protein but a mix of heart-type and adipocyte-type fatty acid-binding protein. J Biol Chem 271:19943-19949
26. Wang M, Liu YE, Ni J, Aygun B, Goldberg ID, Shi YE (2000) Induction of mammary differentiation by mammary-derived growth inhibitor-related gene that interacts with an omega-3 fatty acid on growth inhibition of breast cancer cells. Cancer Res 60:6482-6487
27. Zhang D, Gaussin V, Taffet GE, Belaguli NS, Yamada M, Schwartz RJ, Michael LH, Overbeek PA, Schneider MD (2000) TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nature Med 6:556-563
28. Zimmerman AW, Veerkamp JH (1998) Members of the fatty acid-binding protein family inhibit cell-free protein synthesis. FEBS Lett 437:183-186
29. Zimmerman AW, Veerkamp JH (2002) New insights into the structure and function of fatty acid-binding proteins. Cell Mol Life Sci 59:1096-1116
30. Zschiesche W, Kleine AH, Spitzer E, Veerkamp JH, Glatz JF (1995) Histochemical localization of heart-type fatty-acid binding protein in human and murine tissues. Histochem Cell Biol 103:147-156